Skip to main content
Fig. 3 | Journal of Experimental & Clinical Cancer Research

Fig. 3

From: Synthetic Bax-Anti Bcl2 combination module actuated by super artificial hTERT promoter selectively inhibits malignant phenotypes of bladder cancer

Fig. 3

Silencing ETS-1 inhibited the activity of artificial hTERT promoter in bladder cancer cells. Dual luciferase assay system was used to detect the activity of artificial hTERT promoter at 48 h after transfection. The activity of artificial hTERT promoter in the group co-transfected with ETS-1 shRNA was obviously lower than that in the group co-transfected with negative control shRNA. All data are shown as mean ± S.D.

Back to article page